Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01761734 · ClinicalTrials.gov registry record · NA
Pilot Text Message for Influenza Vaccination
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
NCT01761734 is a NA study that has completed, run by Columbia University. The registered enrollment target is 1,000 participants.
The verdict
NCT01761734, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
Influenza is an important and potentially preventable cause of morbidity and mortality, yet only 46% of U.S. adults were vaccinated by the end of the 2011-12 influenza season despite influenza vaccination being widely recommended, effective, and safe. Influenza vaccination rates are even lower in racial/ethnic minority groups. In order to address the problem of low influenza vaccination rates in minority adults, we plan to build on the well-accepted practice of immunization recall-reminders and the emerging practice of using text message to pilot the feasibility of using text messaging to improve influenza vaccination coverage rates in a low health literacy, largely minority, publicly insured adult population.
Interventions
- BEHAVIORAL text message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01761734
The ClinicalTrials.gov registry entry for NCT01761734 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which text message is the first listed.
NCT01761734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01761734 about?
NCT01761734 is a clinical study titled "Pilot Text Message for Influenza Vaccination". Influenza is an important and potentially preventable cause of morbidity and mortality, yet only 46% of U.S. adults were vaccinated by the end of the 2011-12 influenza season despite influenza vaccination being widely recommended, effective, and safe. Influenza vaccination rates are even lower in ra...
What is the current status of trial NCT01761734?
This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2013-01. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01761734?
The interventions under investigation include: text message (BEHAVIORAL).
Who is sponsoring clinical trial NCT01761734?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.